Summary
Lihu Yang is a seasoned drug discovery leader with over three decades of medicinal chemistry experience, currently heading Discovery Chemistry for UCB in the US with a focus on macrocyclic peptides and targeted protein degradation. He joined UCB after a 26-year tenure at Merck where he built and led collaborative, cross-border chemistry programs that delivered multiple preclinical candidates and advanced clinical assets. Known for pioneering virtual external research models and forging deep Asia-Pacific innovation networks, he combines hands-on chemistry expertise with strategic partnership-building across academia, biotech, and CROs. He has led disease-focused efforts from tuberculosis to oncology and immunology, and teaches drug discovery courses internationally, reflecting a commitment to capacity building and scientific exchange. Based in Cambridge, MA, he also brings a global perspective shaped by extensive fieldwork and advisory roles in low-resource settings.
9 years of coding experience
7 years of employment as a software developer
PhD Organic Synthesis, PhD Organic Synthesis at Rice University
BS Chemistry, BS Chemistry at Nankai University
English, Chinese